Gemer Forte 2 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 850mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake and utilization. This dual mechanism addresses hyperglycemia through complementary pathways, making Gemer Forte 2 effective in patients inadequately controlled by diet and exercise alone or monotherapy. The prolonged-release formulation ensures a steady plasma concentration, minimizing gastrointestinal side effects commonly associated with metformin immediate-release. Gemer Forte 2 should be administered as prescribed, typically once daily with meals to reduce gastrointestinal discomfort. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to hypoxia, as these may increase the risk of lactic acidosis. Regular monitoring of blood glucose, renal function, and potential adverse effects is essential during therapy. This combination is contraindicated in type 1 diabetes, diabetic ketoacidosis, and hypersensitivity to its components. Gemer Forte 2 offers an effective therapeutic option for glycemic control in type 2 diabetes when lifestyle modifications alone are insufficient.